A LOW BASELINE BLOOD NEUTROPHIL COUNT AND A HIGH PERCENTAGE OF TREG AMONG LEUCOCYTES ARE ASSOCIATED WITH AN INCREASED OVERALL SURVIVAL OF RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB

作者:Quillien V; Carpentier A; Gey A; Avril T; Tartour E; Sejalon F; Campillo Gimenez B; Vauleon E
来源:12th Meeting of the European-Association-of-Neuro-Oncology, 2016-10-12 to 2016-10-16.
  • 出版日期2016-10